In this episode of Divergent States, 3L1T3 sits down with Betty Aldworth, the new co-president of MAPS, as she steps into shared leadership with Ismail Ali following Rick Doblin’s four-decade run. Betty brings decades of experience in drug policy reform, from Colorado’s 2012 cannabis legalization campaign to leading Students for Sensible Drug Policy, and now helps guide MAPS through one of the movement’s most pivotal moments: the FDA’s rejection of Lycos Therapeutics’ MDMA-assisted therapy ap...
All content for Divergent States is the property of Divergent States and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
In this episode of Divergent States, 3L1T3 sits down with Betty Aldworth, the new co-president of MAPS, as she steps into shared leadership with Ismail Ali following Rick Doblin’s four-decade run. Betty brings decades of experience in drug policy reform, from Colorado’s 2012 cannabis legalization campaign to leading Students for Sensible Drug Policy, and now helps guide MAPS through one of the movement’s most pivotal moments: the FDA’s rejection of Lycos Therapeutics’ MDMA-assisted therapy ap...
Wendy Tucker on the Shulgin Legacy & the Future of the Farm: Preserving Psychedelic History
Divergent States
48 minutes
9 months ago
Wendy Tucker on the Shulgin Legacy & the Future of the Farm: Preserving Psychedelic History
In this profound episode of Divergent States, we welcome Wendy Tucker, daughter of Ann Shulgin and stepdaughter of the legendary Sasha Shulgin, the "Godfather of Ecstasy." Wendy shares intimate stories of growing up at the iconic Shulgin Farm, working alongside Sasha in his lab, and her mission to preserve their legacy through the Shulgin Foundation. Key Topics Covered: Sasha’s Lab & Humble Genius: Wendy recounts behind-the-scenes moments with Sasha, his playful humor, and the creation of...
Divergent States
In this episode of Divergent States, 3L1T3 sits down with Betty Aldworth, the new co-president of MAPS, as she steps into shared leadership with Ismail Ali following Rick Doblin’s four-decade run. Betty brings decades of experience in drug policy reform, from Colorado’s 2012 cannabis legalization campaign to leading Students for Sensible Drug Policy, and now helps guide MAPS through one of the movement’s most pivotal moments: the FDA’s rejection of Lycos Therapeutics’ MDMA-assisted therapy ap...
